Difference between revisions of "Apligraf"
Jump to navigation
Jump to search
m |
m (wikify skin) |
||
| (10 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
<!-- [[Image:Alloderm-logo.jpg|right|thumb|]] --> | <!-- [[Image:Alloderm-logo.jpg|right|thumb|]] --> | ||
| − | Apligraf is a synthetic skin created from harvested foreskins.<ref>{{ | + | '''Apligraf''' is a synthetic [[skin]] created from harvested foreskins.<ref>{{REFweb |
| − | | quote=Human keratinocytes and fibroblasts are derived from neonatal foreskins | + | |quote=Human keratinocytes and fibroblasts are derived from neonatal foreskins |
| − | | | + | |url=http://www.apligraf.com/professional/what_is_apligraf/how_is_it_made/ |
| − | | | + | |title=Apligraf: How Is It Made? |
| − | | | + | |last= |
| − | | | + | |first= |
| − | | | + | |publisher=Organogenesis |
| − | | | + | |date= |
| − | | accessdate=2011-03-06 | + | |accessdate=2011-03-06 |
| − | }}</ref> It is [[FDA]] approved,<ref>{{ | + | }}</ref> It is [[FDA]] approved,<ref>{{REFweb |
| − | | quote=Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998). | + | |quote=Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998). |
| − | | | + | |url=http://www.organogenesis.com/products/bioactive_woundhealing/apligraf.html |
| − | | | + | |title=Apligraf |
| − | | | + | |last= |
| − | | | + | |first= |
| − | | | + | |publisher=Organogenesis |
| − | | | + | |date= |
| − | | accessdate=2011-03-06 | + | |accessdate=2011-03-06 |
| − | }}</ref> and it is made and sold by [[Organogenesis]], | + | }}</ref> and it is made and sold by [[Organogenesis]], a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf. |
== Apligraph Oral == | == Apligraph Oral == | ||
Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref>{{REFnews | Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref>{{REFnews | ||
| − | | last= | + | |last= |
| − | | first | + | |first= |
| − | + | |url=http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf | |
| − | | url=http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/CellularTissueandGeneTherapiesAdvisoryCommittee/UCM284112.pdf | + | |title=November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript |
| − | | title=November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript | + | |date=2011-11-17 |
| − | | date= | + | |publisher=FDA |
| − | | publisher=FDA | + | |quote= |
| − | | quote= | + | |accessdate=2011-12-20 |
| − | | accessdate=2011-12-20 | ||
}}</ref> | }}</ref> | ||
| − | + | <!-- 404: Sponsor slides: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/cellulartissueandgenetherapiesadvisorycommittee/ucm284480.pdf --> | |
| − | Sponsor slides: http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/bloodvaccinesandotherbiologics/cellulartissueandgenetherapiesadvisorycommittee/ucm284480.pdf | ||
| − | |||
{{REF}} | {{REF}} | ||
| − | [[Category:Foreskin | + | [[Category:Foreskin product]] |
| − | [[Category:Financial | + | [[Category:Financial gain]] |
| − | |||
| − | [[Category: | + | [[Category:From CircLeaks]] |
[[Category:From IntactWiki]] | [[Category:From IntactWiki]] | ||
| + | |||
| + | [[de:{{FULLPAGENAME}}]] | ||
Latest revision as of 15:56, 27 December 2021
Apligraf is a synthetic skin created from harvested foreskins.[1] It is FDA approved,[2] and it is made and sold by Organogenesis, a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.
Apligraph Oral
Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."[3]
References
- ↑
Apligraf: How Is It Made?
, Organogenesis. Retrieved 6 March 2011.
Quote:Human keratinocytes and fibroblasts are derived from neonatal foreskins
- ↑
Apligraf
, Organogenesis. Retrieved 6 March 2011.
Quote:Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).
- ↑
(17 November 2011)."November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript", FDA. Retrieved 20 December 2011.
